These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 14508087)
1. Targeting BCL-2-related proteins in cancer therapy. Manion MK; Hockenbery DM Cancer Biol Ther; 2003; 2(4 Suppl 1):S105-14. PubMed ID: 14508087 [TBL] [Abstract][Full Text] [Related]
2. Bcl-2-related proteins as drug targets. O'Neill JW; Hockenbery DM Curr Med Chem; 2003 Aug; 10(16):1553-62. PubMed ID: 12871126 [TBL] [Abstract][Full Text] [Related]
3. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells. Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246 [TBL] [Abstract][Full Text] [Related]
5. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Chan SL; Yu VC Clin Exp Pharmacol Physiol; 2004 Mar; 31(3):119-28. PubMed ID: 15008953 [TBL] [Abstract][Full Text] [Related]
6. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy. Shin JS; Ha JH; Chi SW Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622 [TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides and non-peptidic molecules as probes of structure and function of Bcl-2 family proteins and modulators of apoptosis. Liu D; Huang Z Apoptosis; 2001 Dec; 6(6):453-62. PubMed ID: 11595835 [TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma. Ozvaran MK; Cao XX; Miller SD; Monia BA; Hong WK; Smythe WR Mol Cancer Ther; 2004 May; 3(5):545-50. PubMed ID: 15141012 [TBL] [Abstract][Full Text] [Related]
9. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602 [TBL] [Abstract][Full Text] [Related]
11. The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens. Thor Straten P; Andersen MH Oncotarget; 2010 Aug; 1(4):239-245. PubMed ID: 21304176 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells. Bettaieb A; Dubrez-Daloz L; Launay S; Plenchette S; Rébé C; Cathelin S; Solary E Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):307-18. PubMed ID: 12769775 [TBL] [Abstract][Full Text] [Related]
13. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Lin B; Kolluri SK; Lin F; Liu W; Han YH; Cao X; Dawson MI; Reed JC; Zhang XK Cell; 2004 Feb; 116(4):527-40. PubMed ID: 14980220 [TBL] [Abstract][Full Text] [Related]
14. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666 [TBL] [Abstract][Full Text] [Related]
15. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Rashmi R; Kumar S; Karunagaran D Carcinogenesis; 2005 Apr; 26(4):713-23. PubMed ID: 15661804 [TBL] [Abstract][Full Text] [Related]
16. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells. Song L; Coppola D; Livingston S; Cress D; Haura EB Cancer Biol Ther; 2005 Mar; 4(3):267-76. PubMed ID: 15753661 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548 [TBL] [Abstract][Full Text] [Related]
19. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659 [TBL] [Abstract][Full Text] [Related]
20. Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. O'Neill J; Manion M; Schwartz P; Hockenbery DM Biochim Biophys Acta; 2004 Dec; 1705(1):43-51. PubMed ID: 15585172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]